Independence Bank of Kentucky’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
8,905
-347
-4% -$18.8K 0.04% 234
2026
Q1
$581K Buy
9,252
+2,455
+36% +$196K 0.07% 194
2025
Q4
$648K Buy
6,797
+1,007
+17% +$98.7K 0.08% 185
2025
Q3
$565K Buy
5,790
+5,450
+1,603% +$564K 0.07% 199
2025
Q2
$36.5K Buy
340
+37
+12% +$3.74K 0.01% 427
2025
Q1
$30.6K Buy
303
+30
+11% +$3.02K ﹤0.01% 436
2024
Q4
$24.4K Buy
273
+225
+469% +$19.8K ﹤0.01% 459
2024
Q3
$4.02K Buy
+48
New +$3.78K ﹤0.01% 536

Other funds holding BSX

Independence Bank of Kentucky's BSX Position: Q2 2026 in Review

Independence Bank of Kentucky reduced its Boston Scientific (BSX) stake by 3.8% in Q2 2026, selling an estimated $18.8K and leaving 8,905 shares worth $380K. The position accounts for 0.04% of the portfolio, ranked #234.

Independence Bank of Kentucky first reported a position in BSX in Q3 2024 and has held it in 8 quarters since. The position peaked at $648K in Q4 2025. 554 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Independence Bank of Kentucky held 8,905 shares of Boston Scientific worth $380K as of Q2 2026.
  • Independence Bank of Kentucky sold 347 Boston Scientific shares in Q2 2026, an estimated $18.8K.
  • Boston Scientific made up 0.04% of Independence Bank of Kentucky's portfolio in Q2 2026, its #234 holding.
  • Independence Bank of Kentucky first reported a position in Boston Scientific in Q3 2024 and has held it in 8 quarters since.
  • Independence Bank of Kentucky's Boston Scientific position peaked at $648K in Q4 2025.
  • 554 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Independence Bank of Kentucky's 13F filing for Q2 2026, filed 13 Jul 2026.